Max Link insider trades: Alexion Pharmaceuticals (ALXN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Max reports to the SEC
and 4 more companies
Open-market buys and sales
24 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 3, 2014 | ALXN | ↓ Sell | 40,000 | $155.16 | $6.2M | Direct | Feb 5, 2014 (2d) |
| Dec 10, 2012 | CLSN | ↑ Buy | 14,000 | $7.60 | $106K | Direct | Dec 11, 2012 (1d) |
| Aug 14, 2012 | ALXN | ↓ Sell | 99,673 | $103.89 | $10.4M | Direct | Aug 15, 2012 (1d) |
| Feb 23, 2012 | CYTR | ↑ Buy | 205,329 | $0.32 | $66K | Direct | Feb 24, 2012 (1d) |
| Jul 25, 2011 | CLSN | ↑ Buy | 46,838 | $4.27 | $200K | Direct | Jul 27, 2011 (2d) |
| May 26, 2011 | CLSN | ↑ Buy | 34,542 | $2.77 | $96K | Direct | May 31, 2011 (5d) |
| Feb 28, 2011 | ALXN | ↓ Sell | 47,637 | $95.00 | $4.5M | Direct | Mar 1, 2011 (1d) |
| Feb 22, 2011 | ALXN | ↓ Sell | 47,367 | $95.00 | $4.5M | Direct | Feb 23, 2011 (1d) |
| Feb 18, 2010 | ALXN | ↓ Sell | 40,000 | $49.34 | $2.0M | Direct | Feb 23, 2010 (5d) |
| Dec 22, 2009 | CLSN | ↑ Buy | 10,000 | $3.00 | $30K | Direct | Dec 23, 2009 (1d) |
| Aug 10, 2009 | CLSN | ↑ Buy | 15,000 | $3.71 | $56K | Direct | Aug 11, 2009 (1d) |
| May 13, 2009 | CLSN | ↑ Buy | 15,000 | $3.90 | $59K | Direct | May 14, 2009 (1d) |
| Apr 27, 2009 | ALXN | ↓ Sell | 40,000 | $33.94 | $1.4M | Direct | Apr 29, 2009 (2d) |
| Nov 19, 2008 | CLSN | ↑ Buy | 2,100 | $2.70 | $6K | Direct | Nov 21, 2008 (2d) |
| Nov 17, 2008 | CLSN | ↑ Buy | 7,100 | $2.76 | $20K | Direct | Nov 18, 2008 (1d) |
| May 18, 2007 | CLN | ↑ Buy | 10,000 | $4.84 | $48K | Direct | May 21, 2007 (3d) |
| Mar 9, 2007 | DSCO | ↑ Buy | 40,000 | $2.09 | $84K | Direct | Mar 13, 2007 (4d) |
| Feb 27, 2007 | CLN | ↑ Buy | 10,000 | $3.49 | $35K | Direct | Mar 1, 2007 (2d) |
| Feb 26, 2007 | CLN | ↑ Buy | 10,000 | $3.50 | $35K | Direct | Feb 27, 2007 (1d) |
| Aug 10, 2006 | ALXN | ↓ Sell | 16,580 | $31.60 | $524K | Direct | Sep 6, 2006 (27d) |
| Mar 17, 2006 | CLN | ↑ Buy | 10,000 | $4.03 | $40K | Direct | Mar 17, 2006 (0d) |
| Nov 1, 2005 | ALXN | ↑ Buy | 2,500 | $21.76 | $54K | Direct | Nov 2, 2005 (1d) |
| Oct 10, 2005 | ALXN | ↑ Buy | 15,000 | $26.77 | $402K | Direct | Oct 11, 2005 (1d) |
| May 24, 2005 | CLN | ↑ Buy | 100,000 | $0.41 | $41K | Direct | May 25, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Max Link's insider trades
Max Link is a director at Alexion Pharmaceuticals (ALXN). Since May 24, 2005, Max has reported 17 open-market purchases worth $1.4M and 7 sales worth $29.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (56 filings), option exercises (12 filings), other transactions (5 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALXN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.